Showing 1 - 11 results of 11 for search 'Parmar Mahesh', query time: 0.04s
Refine Results
-
1
-
2
Survival analysis : a practical approach / by 264092 Parmar, Mahesh K. B., Machin, David
Published 1995 -
3
A new measure of predictive ability for survival models by Choodari-Oskooei Babak, Royston Patrick, Parmar Mahesh KB
Published 2011-12-01Article -
4
-
5
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial by Dearnaley David P, Clarke Noel W, James Nicholas D, Parmar Mahesh KB, Sydes Matthew R, Mason Malcolm D, Morgan Rachel C, Sanders Karen, Royston Patrick
Published 2009-06-01
Article -
6
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial by Menon Usha, Gentry-Maharaj Aleksandra, Burnell Matthew, Ryan Andy, Kalsi Jatinderpal K, Singh Naveena, Dawnay Anne, Fallowfield Lesley, McGuire Alistair J, Campbell Stuart, Skates Steven J, Parmar Mahesh, Jacobs Ian J
Published 2023-05-01
Article -
7
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials by Menon Usha, Gentry-Maharaj Aleksandra, Burnell Matthew, Apostolidou Sophia, Ryan Andy, Kalsi Jatinderpal K, Singh Naveena, Fallowfield Lesley, McGuire Alistair J, Campbell Stuart, Skates Steven J, Dawnay Anne, Parmar Mahesh, Jacobs Ian J
Published 2023-08-01
Article -
8
Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial by Sydes Matthew R, James Nicholas D, Mason Malcolm D, Clarke Noel W, Amos Claire, Anderson John, de Bono Johann, Dearnaley David P, Dwyer John, Jovic Gordana, Ritchie Alastair, Russell Martin, Sanders Karen, Thalmann George, Parmar Mahesh KB
Published 2011-12-01Article -
9
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial by Sydes Matthew R, Parmar Mahesh KB, Mason Malcolm D, Clarke Noel W, Amos Claire, Anderson John, de Bono Johann, Dearnaley David P, Dwyer John, Green Charlene, Jovic Gordana, Ritchie Alastair WS, Russell J, Sanders Karen, Thalmann George, James Nicholas D
Published 2012-09-01
Article -
10
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials by Woolas Robert, Mould Tim, Jenkins Howard, Williamson Karin, Herod Jonathan, Oram David, Godfrey Keith, Amso Nazar N, Seif Mourad W, Parmar Mahesh, Skates Steven, Kalsi Jatinderpal, Habib Mariam, Apostolidou Sophia, Ryan Andy, Gentry-Maharaj Aleksandra, Burnell Matthew, Murdoch John, Dobbs Stephen, Leeson Simon, Cruickshank Derek, Campbell Stuart, Fallowfield Lesley, Jacobs Ian, Menon Usha
Published 2011-03-01
Article -
11
Evaluating primary endpoints for COVID-19 therapeutic trials to assess recovery by Douin, David J., Siegel, Lianne, Grandits, Greg, Phillips, Andrew, Aggarwal, Neil R., Baker, Jason, Brown, Samuel M., Chang, Christina C., Goodman, Anna L., Grund, Birgit, Higgs, Elizabeth S., Hough, Catherine L., Murray, Daniel D., Paredes, Roger, Parmar, Mahesh, Pett, Sarah, Polizzotto, Mark N., Sandkovsky, Uriel, Self, Wesley H., Young, Barnaby Edward, Babiker, Abdel G., Davey, Victoria J., Kan, Virginia, Gelijns, Annetine C., Matthews, Gail, Thompson, B. Taylor, Lane, H. Clifford, Neaton, James D., Lundgren, Jens D., Ginde, Adit A.
Published 2023
Journal Article